Deltacortril

Legal status and availability in the UK

Deltacortril (prednisolone) is a prescription-only medicine (POM) in the UK.

In our online pharmacy, Deltacortril is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

Clinical effectiveness in the UK

How well do steroid tablets and pulses work in everyday NHS practice?

In NHS settings prednisolone, commonly supplied as Deltacortril for oral use, remains a backbone treatment for acute inflammatory flares such as asthma and COPD exacerbations and many rheumatology flares.

Prompt treatment gives rapid symptom relief in acute exacerbations, although bothersome short‑term side effects can occur, including sleep disturbance, appetite increase and mood swings.

For severe allergic reactions and neurological relapses many clinicians favour methylprednisolone IV preparations because injectable strengths are available from 40 mg up to 1 g vials for pulse therapy.

Methylprednisolone is described as marginally more potent with less mineralocorticoid activity compared with prednisolone.

Monitor and document counselling and shared decision‑making in NHS electronic records, and record steroid cumulative exposure where possible.

Common adverse events to watch for in community and inpatient practice include hyperglycaemia, sleep disturbance, mood change and GI upset.

Clinical pharmacists often reconcile steroid dosing with comorbidities and advise on steroid tapers to reduce adrenal suppression risk.

Indications and expanded uses (MHRA‑approved vs off‑label)

Which uses are routine and when is off‑label prescribing employed with governance?

MHRA‑labelled indications for systemic corticosteroids include a broad range of inflammatory, allergic and autoimmune conditions.

Prednisolone tablets such as Deltacortril are routinely used for asthma exacerbations, rheumatoid arthritis flares and several dermatological and ENT inflammatory conditions within their licensed scope.

Off‑label NHS uses include short bridging therapy when starting DMARDs, adjunct short courses in orbital cellulitis and peritumoral symptom control where local formularies and clinician judgement support use.

Methylprednisolone is used for similar indications, and IV pulsed dosing of 500–1000 mg daily for 3–5 days is a recognised approach for severe relapses such as in multiple sclerosis.

For any off‑label prescription document the clinical rationale, obtain appropriate consent and set a monitoring plan as required by NHS prescribing governance.

Live vaccines are contraindicated during significant or high‑dose immunosuppression and should be avoided until steroid exposure is sufficiently reduced.

When consulting the SmPC or local Trust formulary, check indication specifics, dosing and monitoring recommendations before prescribing.

Composition and brand landscape

What exactly is in these medicines and which brands are supplied in the UK?

The active ingredient of Deltacortril is prednisolone, a systemic glucocorticoid; Deltacortril Enteric is supplied as gastro‑resistant tablets of 2.5 mg and 5 mg.

Methylprednisolone (Medrone tablets, Solu‑Medrone injection) is a related corticosteroid used for similar indications.

Prednisolone products such as Deltacortril remain the common oral option for many NHS clinicians for flares that require a flexible oral steroid.

Deltacortril is manufactured by Pfizer, and generic prednisolone tablets are also widely used in the NHS.

The ATC code of prednisolone is H02AB06.

Packaging and supply vary by Trust, so check the local NHS formulary or the SmPC for the exact presentation used in your area.

Where intra‑articular use is considered, specialised formulations and local protocols should guide selection and handling.

Contraindications and special precautions

Who should not take systemic corticosteroids and what local precautions should pharmacists stress?

Absolute contraindications include active uncontrolled infections, particularly systemic fungal infections, and known hypersensitivity to the steroid or excipients.

High‑dose immunosuppression also makes live vaccines contraindicated while the patient is on treatment.

Relative contraindications or caution apply in diabetes mellitus, hypertension, osteoporosis, psychiatric history, peptic ulcer disease and significant hepatic or renal impairment.

Pregnancy requires an individual risk–benefit assessment and usually specialist input for long‑term use.

Practical UK precautions include monitoring blood glucose and blood pressure during courses longer than a few days and considering bone protection for prolonged therapy.

Advise patients about driving and occupational safety if they experience mood changes, dizziness or visual disturbance and follow DVLA guidance where necessary.

Advise moderation of alcohol because it may aggravate GI risk and interact with comorbid liver disease, rather than insisting on an absolute ban for short courses.

Document contraindications, cautions and counselling clearly in the patient record and the NHS Summary Care Record.

Dosage guidelines (NHS‑recommended regimens and adjustments)

What are common NHS regimens and when is tapering necessary?

For prednisolone (Deltacortril), typical short acute regimens such as for asthma exacerbations often use a single daily dose around 40 mg for 3–5 days in adults.

Dermatology and rheumatology dosing is tailored to disease severity and ranges from low‑dose maintenance to higher induction doses as clinically indicated.

Methylprednisolone oral dosing ranges from 4–48 mg/day depending on indication, with IV pulse therapy at 500–1000 mg/day for 3–5 days used in severe exacerbations like MS relapses.

Children receive weight‑based dosing commonly 0.5–2 mg/kg/day with liquid preparations compounded when needed.

Elderly patients should start at the lower end of the dosing range and titrate slowly because of higher susceptibility to adverse effects.

Tapering is recommended when courses exceed 7–10 days to avoid adrenal suppression, with slower tapers needed for longer or higher‑dose regimens.

Always follow the local NHS Trust formulary, the SmPC and the patient’s documented care plan when setting dose and taper schedules.

Interactions overview (drugs, food, MHRA reports)

Which common medicines and agents change steroid effect and what actions do clinicians take?

Enzyme inducers such as rifampicin, phenytoin and carbamazepine can lower steroid levels and may necessitate dose adjustment.

CYP3A4 inhibitors including ketoconazole and ritonavir increase steroid exposure and raise the risk of Cushingoid features and systemic adverse effects.

Concomitant anticoagulants like warfarin need monitoring because steroid therapy can alter INR and bleeding risk.

Live vaccines are contraindicated during significant immunosuppression, while inactivated vaccines generally remain acceptable with clinical advice.

There are no major food interactions, but alcohol can worsen GI upset and liver risk and caffeine may exacerbate steroid‑related insomnia or anxiety.

Psychiatric reactions and hyperglycaemia are among the commonly reported adverse effects, particularly with high‑dose regimens.

Clinical actions include medication review, additional monitoring for glycaemia and blood pressure, and adjusting doses when interacting agents are started or stopped.

Comparable medicines and NHS preferences

Which alternatives do clinicians consider and how does the NHS choose between them?

Common comparators include methylprednisolone (Medrone) and dexamethasone, each with different potency and duration profiles.

Dexamethasone is more potent and longer acting, useful for cerebral oedema and antiemetic support in chemotherapy, while methylprednisolone is often preferred for IV pulses.

Prednisolone (Deltacortril) is a flexible oral option for many flares in primary and secondary care.

NHS choices are influenced by potency, mineralocorticoid effect, monitoring needs and formulation availability.

Pros and cons centre on onset of action, metabolic and psychiatric adverse‑effect profiles, and practicalities such as tablet strengths and injectable vial sizes for acute care.

Clinicians align drug choice with indication, route of administration, comorbidities and local formulary guidance to optimise effectiveness and safety.

FAQ — common NHS patient questions

• Will Deltacortril make me gain weight?

  Short courses may increase appetite and cause transient fluid retention, but significant weight gain is usually seen with prolonged or repeated high‑dose therapy.

  Eat balanced meals, watch portion sizes and discuss any concerns with your pharmacist or GP.

• Can I drink alcohol while taking steroid tablets?

  Small amounts of alcohol during a short course are not strictly contraindicated, but alcohol can increase gastrointestinal upset and may magnify liver risks.

  Avoid excess drinking and tell the pharmacist if you have liver disease.

• Do I need to stop vaccines?

  Live vaccines are contraindicated during substantial immunosuppression; for routine inactivated vaccines consult your GP or practice nurse for timing advice.

• What if I miss a dose?

  Take the missed dose as soon as you remember unless it is close to the next scheduled dose, and do not double up.

  For complex tapering schedules seek pharmacist or GP advice rather than guessing.

Report adverse effects via the MHRA Yellow Card scheme and contact NHS 111 or your GP for severe or worrying symptoms.

Guidelines for proper use — pharmacist counselling and NHS support portals

What should pharmacists cover in a short counselling chat about systemic steroids?

Confirm the indication and dosing schedule and advise that steroids are usually taken in the morning to mimic natural cortisol rhythm unless otherwise directed.

Explain expected benefits and common short‑term side effects and highlight red flags that require urgent assessment such as severe mood changes or signs of infection.

Use a checklist to confirm comorbidities including diabetes, hypertension and osteoporosis, concurrent medicines and current vaccination status.

Document counselling in the NHS Summary Care Record and advise patients to report adverse events to the MHRA Yellow Card scheme.

Signpost NHS.uk, local Trust formularies, specialist nurse teams and patient portals for repeat prescriptions and further information.

Monitoring schedule suggestions include blood pressure and glucose checks during and after longer courses, and bone health review for prolonged therapy.

Delivery across the United Kingdom